tiprankstipranks
Syndax Pharmaceuticals Inc (DE:1T3)
FRANKFURT:1T3
Germany Market

Syndax Pharmaceuticals (1T3) Blogger Opinions & Sentiment

4 Followers

Blogger Sentiment

Bullish: 100.00%
Sector Average
Bullish
DE:1T3 Blogger sentiment is based on 5 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
60% SeekingAlpha
20% Zacks
20% Investing
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Syndax Pharmaceuticals (SNDX - Free Report) reports Q2 loss, lags revenue estimates
Zacks
A Fresh Look At Syndax Pharmaceuticals
SeekingAlpha
Syndax Pharma: Continuing Execution In AML
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of DE:1T3?
Seeking Alpha’s Brendan O'Boyle has a Bullish Sentiment.
    What do Motley Fool contributors think of DE:1T3?
    Currently there's no blogger sentiment for DE:1T3.
    What Is DE:1T3’s Blogger Sentiment?
    DE:1T3’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for DE:1T3?
      The most recent blogger prediction for DE:1T3 was made by NASDAQ:SNDX, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          IOVAIovance Biotherapeutics
          VERAVera Therapeutics
          KURAKura Oncology
          NUVBNuvation Bio
          DFTXDefinium Therapeutics